0001213900-22-057529 Sample Contracts

Underwriting Agreement
Underwriting Agreement • September 21st, 2022 • Clearmind Medicine Inc. • Pharmaceutical preparations • New York
AutoNDA by SimpleDocs
Cooperation Agreement
Cooperation Agreement • September 21st, 2022 • Clearmind Medicine Inc. • Pharmaceutical preparations

This Cooperation Agreement (“Agreement”) is entered into as of March 7, 2022 (“Effective Date”) between Scisparc Ltd. with an office at 20 Raoul Wallenberg St. Building A, 2nd Fl. (“Scisparc”) and ClearMind Medicine Inc. with offices at 101 – 1220 W 6 Ave Vancouver, BC V6H 2R8, on behalf of itself and its affiliates (“CM”). Each shall be referred hereinafter as “Party” and together – as “Parties”.

FORM OF INDEMNITY AGREEMENT
Form of Indemnity Agreement • September 21st, 2022 • Clearmind Medicine Inc. • Pharmaceutical preparations • British Columbia

NOW THEREFORE, in consideration of the premises and the covenants and agreements herein contained, the parties agree as follows:

Contract
Clearmind Medicine Inc. • September 21st, 2022 • Pharmaceutical preparations • New York

THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING [●], 2022 (THE “EFFECTIVE DATE”) TO ANYONE OTHER THAN (I) AEGIS CAPITAL CORP. OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING FOR WHICH THIS PURCHASE WARRANT WAS ISSUED TO THE UNDERWRITER AS CONSIDERATION (THE “OFFERING”), OR (II) A BONA FIDE OFFICER OR PARTNER OF AEGIS CAPITAL CORP.

AMENDMENT TO THE SUBSCRIPTION AGREEMENT
The Subscription Agreement • September 21st, 2022 • Clearmind Medicine Inc. • Pharmaceutical preparations

THIS AMENDMENT (the “Amendment”) to the Subscription Agreement dated February 3, 2022 (the “Agreement”) is made on June 29, 2022, by and between Clearmind Medicine Inc. (the “Corporation”) and Medigus Ltd. (the “Investor”, and together with the Corporation, the “Parties”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!